Washington: A breakthrough has opened the door for the development of a new category of painkillers which may be effective in treating pain related to a number of conditions including cancer, AIDS, migraines and diabetes. The painkillers, called TRPV1 antagonists, can be activated by pepper like chemicals and high temperatures.
The ground breaking project to eliminate the side-effect was led by Andrej A. Romanovsky at Barrow Neurological Institute at St. Joseph`s Hospital and Medical Centre in Arizona and included researchers from Arizona State University. "We think we have found a recipe for making TRPV1 antagonists that do not have this fever-like side effect," says Romanovsky. IANS
Inflation woes: Prices of tomato, green chilli soar
Tutor caught torturing a 3-year-old on CCTV
Shiv Sena MPs `force` fasting Muslim to eat
Don`t take us for granted, NCP warns Congress